23 Nov 2016 16:21
23 November 2016
e-Therapeutics plc
('e-Therapeutics' or 'the Company')
Grant of share options and Directors' dealings
Oxford and Newcastle, UK, 23 November 2016 - e-Therapeutics plc (AIM: ETX) the drug discovery company, announces that on 23 November 2016 the Company granted options over a total of 10,310,000 ordinary shares of 0.1p each to certain executive directors and other employees (the "Optionholders"). The Optionholders are entitled to exercise their options in three tranches (as set out below) on or after the date specified below, if, at the time of exercise, the prevailing market price of the Company's ordinary shares is not less than the price set out below (the "Exercise Price"). Optionholders will be required to pay the Exercise Price to exercise their options.
Number of shares under option Exercise Price Exercise Date
3,436,666 16.76p 23 November 2018
3,436,667 20.95p 23 November 2018
3,436,667 25.14p 23 November 2019
Details of the individual options granted to executive directors are set out below:
Director Number of shares under option
Steve Medlicott 2,000,000
Sean Nicolson 750,000
The options referred to above are otherwise subject to the Rules of the Company's 2013 Performance Share Plan.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a. | Name | Steve Medlicott | ||||||
2 | Reason for notification | |||||||
a. | Position/Status | Director | ||||||
b. | Initial notification/ Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a. | Name | e-Therapeutics plc | ||||||
b. | LEI | N/A | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary shares of 0.1p each ISIN: GB00B2823H99 | ||||||
b. | Nature of the transaction | Grant of options to subscribe for ordinary shares | ||||||
c. | Price(s) and volume(s) |
|
|
|
|
| ||
| Exercise price(s) | Volume(s) |
| |||||
£0.1676 | 666,666 |
| ||||||
| £0.2095 | 666,667 |
| |||||
| £0.2514 | 666,667 |
| |||||
| ||||||||
d. | Aggregated information- Aggregated Volume - Price |
Volume: 2,000,000 options over ordinary shares Price: N/A | ||||||
e. | Date of the transaction | 23 November 2016 | ||||||
f. | Place of the transaction | London Stock Exchange | ||||||
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | |||||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a. | Name | Sean Nicolson | |||
2 | Reason for notification | ||||
a. | Position/Status | Director | |||
b. | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | e-Therapeutics plc | |||
b. | LEI | N/A | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary shares of 0.1p each ISIN: GB00B2823H99 | |||
b. | Nature of the transaction | Grant of options to subscribe for ordinary shares | |||
c. | Price(s) and volume(s) |
| |||
| Exercise Price(s) | Volume(s) |
| ||
£0.1676 | 250,000 |
| |||
| £0.2095 | 250,000 |
| ||
| £0.2514 | 250,000 |
| ||
| |||||
d. | Aggregated information- Aggregated Volume - Price |
Volume: 750,000 Price: N/A | |||
e. | Date of the transaction | 23 November 2016 | |||
f. | Place of the transaction | London Stock Exchange | |||
E-therapeutics (ETX)